IL6 and myocardial ischemia: The lack of an IL‐6 response in PDMC‐mediated cell therapy clearly can be beneficial in the setting of IHD and supports the specificity of laminin/αvβ3 integrin modulation and lack of ERK activation of PDMC paracrine functions.